 | Up a level |
Pattni, Karan, Hungerford, Daniel, Adams, Sarah, Buchan, Iain 
ORCID: 0000-0003-3392-1650, Cheyne, Christopher, García-Fiñana, Marta, Hall, Ian, Hughes, David ORCID: 0000-0002-1287-9994, Overton, Christopher ORCID: 0000-0002-8433-4010, Zhang, Xingna et al (show 1 more authors)
(2021)
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.
[Preprint]
Pattni, Karan, Hungerford, Daniel ORCID: 0000-0002-9770-0163, Adams, Sarah, Buchan, Iain ORCID: 0000-0003-3392-1650, Cheyne, Christopher P, García-Fiñana, Marta ORCID: 0000-0003-4939-0575, Hall, Ian, Hughes, David M ORCID: 0000-0002-1287-9994, Overton, Christopher E, Zhang, Xingna ORCID: 0000-0002-8849-2112 et al (show 1 more authors)
(2022)
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.
BMC Infectious Diseases, 22 (1).
270-.